- Home
- NPT vs ABOS Comparison
NPT vs ABOS Comparison
Compare NPT & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPT
- ABOS
- Stock Information
- Founded
- NPT 2011
- ABOS 1996
- Country
- NPT China
- ABOS United States
- Employees
- NPT N/A
- ABOS N/A
- Industry
- NPT Specialty Chemicals
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- NPT Consumer Discretionary
- ABOS Health Care
- Exchange
- NPT Nasdaq
- ABOS Nasdaq
- Market Cap
- NPT 113.1M
- ABOS 109.6M
- IPO Year
- NPT 2025
- ABOS 2021
- Fundamental
- Price
- NPT $3.69
- ABOS $1.52
- Analyst Decision
- NPT
- ABOS Strong Buy
- Analyst Count
- NPT 0
- ABOS 3
- Target Price
- NPT N/A
- ABOS $7.67
- AVG Volume (30 Days)
- NPT 130.5K
- ABOS 244.5K
- Earning Date
- NPT 11-18-2025
- ABOS 11-12-2025
- Dividend Yield
- NPT N/A
- ABOS N/A
- EPS Growth
- NPT N/A
- ABOS N/A
- EPS
- NPT N/A
- ABOS N/A
- Revenue
- NPT $797,148,640.00
- ABOS N/A
- Revenue This Year
- NPT N/A
- ABOS N/A
- Revenue Next Year
- NPT N/A
- ABOS N/A
- P/E Ratio
- NPT N/A
- ABOS N/A
- Revenue Growth
- NPT 18.51
- ABOS N/A
- 52 Week Low
- NPT $3.14
- ABOS $0.86
- 52 Week High
- NPT $9.18
- ABOS $2.47
- Technical
- Relative Strength Index (RSI)
- NPT N/A
- ABOS 35.32
- Support Level
- NPT N/A
- ABOS $1.50
- Resistance Level
- NPT N/A
- ABOS $2.04
- Average True Range (ATR)
- NPT 0.00
- ABOS 0.16
- MACD
- NPT 0.00
- ABOS -0.07
- Stochastic Oscillator
- NPT 0.00
- ABOS 3.75
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.